CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 136 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 12.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,026,000 | -31.5% | 1,653,988 | 0.0% | 0.02% | -16.7% |
Q1 2022 | $4,416,000 | -42.1% | 1,653,988 | -6.1% | 0.03% | -38.8% |
Q4 2021 | $7,624,000 | -54.7% | 1,760,922 | -46.7% | 0.05% | -57.0% |
Q3 2021 | $16,826,000 | +14.2% | 3,305,940 | +42.0% | 0.11% | +12.9% |
Q2 2021 | $14,739,000 | +1473800.0% | 2,328,353 | +1594662.3% | 0.10% | – |
Q1 2021 | $1,000 | -100.0% | 146 | -100.0% | 0.00% | -100.0% |
Q1 2020 | $6,021,000 | -2.2% | 741,191 | +0.0% | 0.07% | +1.5% |
Q4 2019 | $6,159,000 | +21.3% | 741,144 | +7.8% | 0.07% | -1.5% |
Q3 2019 | $5,076,000 | -33.9% | 687,833 | 0.0% | 0.07% | -30.2% |
Q2 2019 | $7,684,000 | +6.9% | 687,833 | +2.8% | 0.10% | +4.3% |
Q1 2019 | $7,190,000 | -3.0% | 668,833 | +36.2% | 0.09% | -19.3% |
Q4 2018 | $7,414,000 | +2.1% | 490,988 | +25.0% | 0.11% | +17.5% |
Q3 2018 | $7,265,000 | +76.4% | 392,727 | +118.0% | 0.10% | +49.2% |
Q2 2018 | $4,118,000 | +253.2% | 180,127 | +339.3% | 0.06% | +225.0% |
Q1 2018 | $1,166,000 | -37.9% | 41,000 | -53.9% | 0.02% | -39.4% |
Q4 2017 | $1,879,000 | -37.3% | 89,000 | -46.1% | 0.03% | -36.5% |
Q3 2017 | $2,998,000 | -0.8% | 165,000 | -15.4% | 0.05% | -8.8% |
Q2 2017 | $3,023,000 | -10.2% | 195,000 | 0.0% | 0.06% | -12.3% |
Q1 2017 | $3,368,000 | +97.8% | 195,000 | +25.8% | 0.06% | +66.7% |
Q4 2016 | $1,703,000 | -29.9% | 155,000 | 0.0% | 0.04% | -32.8% |
Q3 2016 | $2,430,000 | +255.3% | 155,000 | +131.3% | 0.06% | +222.2% |
Q2 2016 | $684,000 | +26.9% | 67,000 | +59.5% | 0.02% | +38.5% |
Q1 2016 | $539,000 | +157.9% | 42,000 | +320.0% | 0.01% | +116.7% |
Q4 2015 | $209,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |